RUNX2 and colorectal carcinoma: Analysis of CRC specimens further ascertained that RUNX2 mRNA and protein levels were distinctly higher in recurrent tumors (primary and metastatic) than the non-recurrent counterparts, and RUNX2 overexpression correlated tightly with CRC progression, especially the TMN stages and liver/lung metastasis.